These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7796971)

  • 1. New developments in the construction of safer and more versatile pseudorabies virus vaccines.
    Mettenleiter TC
    Dev Biol Stand; 1995; 84():83-7. PubMed ID: 7796971
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of live pseudorabies virus vaccines.
    Kimman TG; Gielkens AL; Glazenburg K; Jacobs L; de Jong MC; Mulder WA; Peeters BP
    Dev Biol Stand; 1995; 84():89-96. PubMed ID: 7796972
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of recombination on the genetic stability of pseudorabies vaccine virus.
    Visser N
    Dev Biol Stand; 1995; 84():97-104. PubMed ID: 7796973
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and immunogenicity of recombinants based on the genetically-engineered vaccinia strain, NYVAC.
    Tartaglia J; Cox WI; Pincus S; Paoletti E
    Dev Biol Stand; 1994; 82():125-9. PubMed ID: 7958466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic engineering of the pseudorabies virus genome to construct live vaccines.
    Post LE; Thomsen DR; Petrovskis EA; Meyer AL; Berlinski PJ; Wardley RC
    J Reprod Fertil Suppl; 1990; 41():97-104. PubMed ID: 2170641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudorabies virus infections in pigs. Role of viral proteins in virulence, pathogenesis and transmission.
    Mulder WA; Pol JM; Gruys E; Jacobs L; De Jong MC; Peeters BP; Kimman TG
    Vet Res; 1997; 28(1):1-17. PubMed ID: 9172836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in the development of vaccines against Aujeszky's disease].
    Mettenleiter TC
    Tierarztl Prax; 1995 Dec; 23(6):570-4. PubMed ID: 8585074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccines against Aujeszy's disease].
    Toma B
    Dev Biol Stand; 1982; 52():407-13. PubMed ID: 6299851
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the protective response induced by NYVAC vaccinia recombinants expressing either gp50 or gII and gp50 of pseudorabies virus.
    Brockmeier SL; Mengeling WL
    Can J Vet Res; 1996 Oct; 60(4):315-7. PubMed ID: 8904669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of swine with a modified live-virus pseudorabies vaccine.
    Bass EP
    Proc Annu Meet U S Anim Health Assoc; 1978; (82):426-32. PubMed ID: 221938
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant-derived modified-live herpesvirus vaccines.
    Kit S
    Adv Exp Med Biol; 1989; 251():219-36. PubMed ID: 2558526
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenicity of bivalent vaccine for reproductive failure of swine induced by pseudorabies virus and porcine parvovirus.
    Mengeling WL; Gutekunst DE; Pirtle EC; Paul PS
    Am J Vet Res; 1981 Apr; 42(4):600-3. PubMed ID: 6277213
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of efficacy and safety of Aujeszky's disease vaccines.
    Lipowski A
    Pol J Vet Sci; 2006; 9(1):75-9. PubMed ID: 16573279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination recommendation for Aujeszky disease].
    Kimman TG
    Tijdschr Diergeneeskd; 1994 May; 119(9):278-81. PubMed ID: 8191487
    [No Abstract]   [Full Text] [Related]  

  • 16. Procedures for the elimination of pseudorabies virus from herds of swine.
    Thawley DG; Gustafson DP; Beran GW
    J Am Vet Med Assoc; 1982 Dec; 181(12):1513-8. PubMed ID: 6298161
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
    Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
    Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biology of pseudorabies (Aujeszky's disease) virus.
    Mettenleiter TC
    Comp Immunol Microbiol Infect Dis; 1991; 14(2):151-63. PubMed ID: 1657509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the resistance of fattening pigs following inoculation with various vaccines at an age of four to nine weeks (author's transl)].
    Tielen MJ; Brus DH; van Exsel AC; Akkermans JP; Rondhuis PR
    Tijdschr Diergeneeskd; 1980 Oct; 105(19):827-34. PubMed ID: 6252658
    [No Abstract]   [Full Text] [Related]  

  • 20. Constancy of Aujeszky's field virus antibody titres in sows repeatedly vaccinated with a gI-negative vaccine.
    Hopp W; Jungblut R
    Acta Vet Hung; 1994; 42(2-3):409-11. PubMed ID: 7810439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.